KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞINDA AŞILANMA; GERÇEKTEN YAPTIRTIYOR MUYUZ?
Kronik obstrüktif akciğer hastalığı (KOAH), tüm dünyada önemli bir mortalite ve morbidite nedenidir. Mortalite artışına neden olan enfensiyonlara bağlı atakları azaltmak için en önemli konulardan biri aşılanmadır. Bu çalışmada, KOAH hastalarında influenza ve pnomokok aşısı ile ilgili bilgi düzeylerini ve yapılma oranlarını saptamayı amaçladık. Çalışmaya 100 KOAH tanılı hasta alındı. Hastaların influenza ve pnömokok aşılarını bilip bilmedikleri ve yaptırıp yaptırmadıkları sorgulandı. Aşıyla ilgili nasıl bilgi edindikleri kaydedildi. Hastaların influenza ve pnömokok aşısını bilme oranı sırasıyla % 49 and %12, yaptırma oranı %40 ve %10 olarak bulundu. KOAH ilaç raporu olanların olmayanlara göre (p=0.049) ve sigarayı bırakmış olanların aktif içenlere göre (p=0.004) influenza aşısını bilme oranları yüksek olduğu, KOAH ilaç raporu olanların olmayanlara göre(p=0.007) influenza aşısını yaptırma oranının da daha yüksek olduğu saptandı. Pnömokok aşısını bilmeyen ve yaptırmayanların erkeklerde kadınlara göre fazla olduğu bulundu (sırasıyla p=0.009 ve p= 0.001). Ayrıca pnömokok aşısını yaptırmayanların eğitim düzeyi düşük olan grupta (okur yazar + ilkokul mezunu grubu) daha yüksek olduğu izlendi (p=0.018). Sonuç olarak, ülkemizde sosyal güvence kapsamında ve rehberlerde olmasına rağmen aşılanma oranının düşük olduğu izlenmiştir. Bu nedenle KOAH hastalarına poliklinik şartlarında grip ve pnömokok aşılaması konusunda daha fazla bilgilendirmesi ve eğitim yapılması gerektiğini düşünmekteyiz.
IMMUNIZATION IN THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE: CAN WE HAVE REALLY DONE IT?
Chronic obstructive pulmonary disease, is an important cause of morbidity and mortality worldwide. Immunization is one of the most important issue in order to reduce the increased mortality due to attacks of the infections. In this study, we aimed to determine the level of knowledge and rates of influenza and pneumococcal vaccination in COPD patients. One hundred consecutive patients with COPD were enrolled into study. Patients were questioned about whether they have known and to be immunized with influenza and pneumococcal vaccination and how they can get information about vaccines were recorded. Awareness rates of patients about influenza and pneumococcal vaccines were found 49% and 12%, immunization rates were found 40% and 10% respectively. In those patients with than without drug report for COPD (p=0.049) and those who quit smoking according the smokers (p=0.004) knowledge rates of influenza vaccine and in drug report group influenza immunization rates (p=0.007) were found higher it was statistically significant. In male group, absence of knowledge and immunization rates with pneumococcal vaccine were higher than female group (p=0.009, p= 0.001 respectively). In addition, immunization without pnemococcal vaccine rate was observed to be higher in low education level group (p=0.018). In conclusion, we revealed that in our country, vaccination rate is low although in the scope of social insurance and the guidelines. Therefore, we suggest that more information and education should be given about influenza and pneumococcal vaccination to COPD patients in outpatient conditions.
___
- 1. Murray CJ, Lopez AD, Alternative projections of
mortality and disability by cause 1990-2020:
Global burden of disease study. Lancet
1997;349:1498-504.
- 2. Seemungal TAR, Donaldson GC, Paul EA, et al.
Effect of exacerbation on quality of life in patients
with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 1998;
157:1418-22.
- 3. Domingo-Salvany A, Lamarca R, Ferrer M,et al.
Health related quality of life and mortality in
male patients with chronic obstructive pulmonary
disease. Am J Respir Crit Care Med 2002;
166:680-5.
- 4. Global Initiative for Chronic Obstructive Lung
Disease. Global strategy fort he diagnosis, management,
and prevention of chronic obstructive
pulmonary disease (2006). www.goldcopd.org
- 5. Donaldson GC, Wedzicha JA. COPD exacerbatins.
1: Epidemiology. Thorax 2006;61:164-8.
- 6. Bovier PA, Chamot E, Bouvier GM, Loutan L. Importance
of patients’ perceptions and general
practitioners’ recommendations in understanding
missed opportunities for immunisations in
Swiss adults. Vaccine 2001; 19:4760-7.
- 7. Jimenez-Garcia R, Arinez-Fernandez MC, GarciaCarballo
M, Hernandez-Barrera V, Miguel AG,
Carrasco-Garrido P. Influenza vaccination coverage
and related factors among Spanish patients
with chronic obstructive pulmonary disease.
Vaccine 2005;23:3679-86.
- 8. Kaufman Z, Green MS. Compliance with influenza
and pneumococcal vaccinations in Israel,
1999-2002. Public Health Rev 2003; 31: 71-9.
- 9. Jimenez-Garcia R, Arinez-Fernandez MC, Hernandez-Barrera
V, Garcia-Carballo MM, de Miguel
AG, Carrasco-Garrido P. Compliance with
influenza and pneumococcal vaccination among
patients with chronic obstructive pulmonary disease
consulting their medical practitioners in
Catalonia, Spain. J Infect 2007; 54: 65-74 (Epub
2006 Oct 16).
- 10.Wongsurakiat P, Maranetra KN, Wasi C, Kositanont
U, Dejsomritrutai W, Charoenratanakul S.
Acute respiratory illness in patients with COPD
and the effectiveness of influenza vaccination:
arandomized controlled study. Chest 2004;
125(6):2011-20.
- 11.Nichol KL, Margolis KL, Wuorenma J, Von Sternberg
T. The efficacy and cost effectiveness of
vaccination against influenza among elderly persons
living in the community. N Engl J Med
1994;331(12):778-84.
- 12.Wongsurakiat P, Lertakyamanee J, Maranetra
KN, Jongriratanakul S, Sangkaew S. Economic
evaluation of influenza vaccination in Thai
chronic obstructive pulmonary disease patients.
J Med Assoc Thai 2003;86(6):497-508.
- 13.Hak E, Hoes AW, Verheij TJ. .Influenza vaccinations:
who needs them and when? Drugs.
2002;62:2413-20.
- 14.Hedlund J, Christenson B, Lundbergh P, Ortqvist
A. Effects of a large-scale intervention with influenza
and 23. valent pneumococcal vaccines in
elderly people: a 1-year follow-up. Vaccine.
2003;21:3906-11.
- 15.Türk Toraks Derneği Kronik Obstrüktif Akciğer
Hastalığı Tanı ve Tedavi Uzlaşı Raporu
2010;1:31-59.
- 16.Global Initiative for Chronic Obstructive Lung
Disease. Global strategy for the diagnosis, management
and prevention of chronic obstructive
pulmonary disease 2009 (www.goldcopd.org)
17.Pesek R, Lockey R. Vaccination of adults with
asthma and COPD. Allergy. In press 2010.
- 18.Nichol KL, Wuorenma J, von Stenberg T. Benefits
of influenza vaccination for low, intermediate-,
and high-risk senior citizens. Arch Intern
Med 1998; 158:1769–76.
- 19.Nichol KL, Baken L, Nelson A. Relation between
influenza vaccination and patient visits, hospitalization,
and mortality in elderly persons with
chronic lung disease. Ann Intern Med 1999;
130:397–403.
- 20.Jimenez R, Larrauri A, Carrasco P, Esteban J,
Gomez-Lopez LI, Gil A. Influenza coverages in
Spain and vaccination-related factors in the
subgroup aged 50-64 years. Vaccine 2003; 21:
3550-5.
- 21.Kamal KM, Madhavan SS, Amonkar MM. Determinants
of adult influenza and pneumonia immunization
rates. J Am Pharm Assoc (Washington,
DC) 2003; 43:403-11.
- 22.Özol D, Özçakar B. Kronik obstrüktif akciğer
hastalarında grip aşılanma oranı. Akciğer Arşivi
2005;6:133-6.
- 23.Taşbakan MS, Pullukçu H ve ark.Kronik obstrüktif
akciğer hastalığı olgularında influenza aşı-
lanma oranları ve bilgi düzeylerinin değerlendirilmesi.
İnfeksiyon Dergisi (Turkish Journal
of Infection) 2007;21 (2):89-92.
- 24.Szucs TD, Muller D. Influenza vaccination coverage
rates in five European countries-a population-based
cross-sectional analysis of two consecutive
influenza seasons. Vaccine 2005; 23:
5055-63.
- 25.Schoefer Y, Schaberg T, Raspe H, et al. Determinants
of influenza and pneumococcal vaccination
in patients with chronic lung diseases. J Infect
2007;55:347-52.
- 26.Schwartz KL, Neale AV, Northrup J, et al. Racial
similarities to standardized offer of influenza
vaccination: a metronet study. J Gen Intern Med
2006; 21: 346–51.
- 27.CDC. Influenza and pneumococcalvaccination
coverage among persons aged >65 YearsUnited
States, 2004-2005. Morb Mortal Wkly Rep
2006;55:1065-8.
- 28.Arinez-Fernandez MC, Carrasco-Garrido P, Garcia-Carballo
M, Hernandez-Barrera V, de M iguel
AG, Jimenez-Garcia R. Determinants of pneumococcal
vaccination among patients with
chronic obstructive pulmonary disease in Spain.
Hum Vaccin 2006; 2:99-104.
- 29.Maria C. Arinez-Fernandez, Pilar CarrascoGarrido,
Angel Gil de Miguel, Rodrigo JimenezGarcia.
Influenza and pneumococcal vaccination
in chronic obstructive pulmonary disease (copd).
Respiratory Medicine:Copd Update 3(2007) 95-
101.
- 30.Centers for Disease Control and Prevention. Prevention
of pneumococcal disease: recommendations
of the Advisory Committee on Immunization
Practices (ACIP). MMWR Recomm Rep
1997;46:1-24.